Related Experiment Video
Updated: Jul 8, 2025

Visualization of DNA Replication in the Vertebrate Model System DT40 using the DNA Fiber Technique
Published on: October 27, 2011
A copper(ii) peptide helicate selectively cleaves DNA replication foci in mammalian cells
Ana Alcalde-Ordóñez1, Natalia Barreiro-Piñeiro2, Bríonna McGorman3
1Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela 15782 Santiago de Compostela Spain.
Abstract:
The use of copper-based artificial nucleases as potential anticancer agents has been hampered by their poor selectivity in the oxidative DNA cleavage process. An alternative strategy to solve this problem is to design systems capable of selectively damaging noncanonical DNA structures that play crucial roles in the cell cycle. We designed an oligocationic CuII peptide helicate that selectively binds and cleaves DNA three-way junctions (3WJs) and induces oxidative DNA damage via a ROS-mediated pathway both in vitro and in cellulo, specifically at DNA replication foci of the cell nucleus, where this DNA structure is transiently generated. To our knowledge, this is the first example of a targeted chemical nuclease that can discriminate with high selectivity 3WJs from other forms of DNA both in vitro and in mammalian cells. Since the DNA replication process is deregulated in cancer cells, this approach may pave the way for the development of a new class of anticancer agents based on copper-based artificial nucleases.
Insights
Researchers developed a novel copper-based peptide helicate that selectively targets and damages three-way DNA junctions (3WJs). This breakthrough offers a promising new strategy for developing targeted anticancer agents by exploiting cancer cells' deregulated DNA replication processes.
Area of Science:
- Biochemistry
- Chemical Biology
- Molecular Oncology
Background:
- Copper-based artificial nucleases show anticancer potential but lack selectivity in DNA cleavage.
- Targeting noncanonical DNA structures, crucial in the cell cycle, offers an alternative strategy for selective cancer therapy.
Purpose of the Study:
- To design a copper-based artificial nuclease with high selectivity for noncanonical DNA structures.
- To investigate the targeted DNA cleavage and anticancer potential of the designed nuclease.
Main Methods:
- Design and synthesis of an oligocationic Cu(II) peptide helicate.
- In vitro and in cellulo studies to assess DNA binding and cleavage selectivity.
- Evaluation of ROS-mediated oxidative DNA damage induction at DNA replication foci.
Main Results:
- The designed helicate selectively binds and cleaves DNA three-way junctions (3WJs) over other DNA forms.
- Oxidative DNA damage is induced via a ROS-mediated pathway both in vitro and in cellulo.
- Targeting occurs specifically at DNA replication foci within the cell nucleus.
Conclusions:
- This study presents the first targeted chemical nuclease with high selectivity for 3WJs in vitro and in mammalian cells.
- The ability to selectively damage 3WJs, which are transiently generated during DNA replication, offers a novel anticancer strategy.
- This approach may lead to a new class of copper-based artificial nucleases for cancer therapy.
More Related Videos
Related Concept Videos
Restarting Stalled Replication Forks
DNA Helicases
DNA Damage can Stall the Cell Cycle
Homologous Recombination
The DNA Replication Fork
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...

